Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jun, 2019 | Pages:
100 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)
The global inflammatory bowel disease treatment market size is expected to reach USD 22.4 billion by 2026, according to a new report by Grand View Research, Inc., registering a 4.4% CAGR during the forecast period. Increasing prevalence and incidence of Crohn's disease and ulcerative colitis is one of the major factors contributing to the market. According to a study published in the NCBI in 2019, the North America incidence of inflammatory bowel disease (IBD) treatment is around 2.2 to 19.2 cases per 100,000 persons per year. It was also published that around 238 per 100,000 population in U.S. were suffering from ulcerative colitis. Furthermore, The Centers for Disease Control and Prevention (CDC) estimates that in U.S., every year nearly 1-1.3 million people suffer from inflammatory bowel disease. In addition, involvement of regulatory bodies for funding and designation is expected to propel the growth of the market. For instance, the Crohn's and Colitis Foundation offers grants and fellowships for research on inflammatory bowel disease (includes Crohn's disease and ulcerative colitis). Growing geriatric population is expected to positively impact the overall market. According to an article published in 2018 in the United States Census Bureau, it is estimated that by 2035, the population aged 65 years and above is expected to reach 78 million, whereas children under the age of 18 might be around 76.7million. Moreover, companies such as Johnson & Johnson Services Inc.; Pfizer Inc.; Takeda Pharmaceutical Company Limited; and AbbVie Inc. are majorly involved in product research and development and this is also considered as one of the major driving factors for the market. Further key findings from the report suggest: • The global inflammatory bowel disease treatment market is anticipated to reach USD 22.4 billion by 2026, exhibiting a CAGR of 4.4% from 2018 to 2026 • Crohn's disease dominated the market by type in 2018 due to increasing incidence of the disease. On the other hand, ulcerative colitis was estimated to be the fastest growing segment owing to presence of strong pipeline products for its treatment • By route of administration, injectables dominated the IBD treatment market in 2018 while oral was estimated to be the fastest growing segment over the forecast period • Aminosalicylic acid (ASAs) was considered to be the largest oral segment in 2018 and JAK inhibitors to be the fastest growing segment • In 2018, TNF-inhibitors dominated the injectables segment while anti-integrins are estimated to be the fastest growing segment • Hospital pharmacy was the largest segment in 2018 with a market share of 36.6% and online pharmacy was anticipated to be the fastest owing to the comfort, flexibility and convenience provided • North America held the dominant share in 2018 owing to presence of key companies in this region. Asia Pacific, on the other hand, was estimated to be the fastest growing region • Some of the key companies operating in this market are Johnson & Johnson Services Inc.; Pfizer Inc.; Takeda Pharmaceutical Company Limited; AbbVie Inc.; Celltrion Healthcare Co., Ltd.; CELGENE CORPORATION; COSMO PHARMACEUTICALS; Innovate Biopharmaceuticals; UCB S.A.; and Gilead Sciences.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market segmentation & scope
1.2. Market definition
1.3. Information procurement
1.3.1. Purchased database
1.3.2. GVR's internal database
1.3.3. Secondary sources & third party perspectives
1.3.4. Primary research
1.4. Information analysis
1.4.1. Data analysis models
1.5. Market formulation & data visualization
1.6. Data validation & publishing
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Global Inflammatory Bowel Disease Treatment Market Variables, Trends & Scope
3.1. Inflammatory bowel disease treatment : Market Lineage outlook
3.1.1. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Pipeline Analysis
3.4. Epidemiology Study
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.1.1. Rising prevalence of Crohn's disease and ulcerative colitis
3.5.1.2. Strong pipeline products
3.5.1.3. Increasing geriatric population
3.5.1.4. Emerging of biosimilars
3.5.1.5. Involvement of regulatory bodies for funding and designation.
3.5.2. Market Restraint Analysis
3.5.2.1. High cost of treatment
3.5.2.2. Lack of early diagnosis
3.6. Inflammatory bowel disease treatment Market Analysis Tools
3.6.1. Industry Analysis - Porter's
3.6.1.1. Supplier Power: Moderate due to large presence of many suppliers
3.6.1.2. Buyer Power: Moderate owing to presence of large number of providers
3.6.1.3. Substitution Threat: Moderate due to existence of home-remedies
3.6.1.4. Threat from new entrant: Moderate due to high buyer switching cost
3.6.1.5. Competitive rivalry: High due to presence of key players involved in product development
3.7. PESTEL Analysis
3.7.1. Political Landscape
3.7.2. Environmental Landscape
3.7.3. Social Landscape
3.7.4. Technology Landscape
3.7.5. Legal Landscape
3.8. Major Deals & Strategic Alliances Analysis
3.8.1. Joint Ventures
3.8.2. Mergers & Acquisitions
3.8.3. Licensing & Partnership
3.8.4. Technology Collaborations
3.8.5. Strategic Divestments
Chapter 4. Inflammatory Bowel Disease Treatment Market: Type Estimates & Trend Analysis
4.1. Definitions & Scope
4.2. Type market share analysis, 2018 & 2026
4.3. Type Dashboard
4.4. Global Inflammatory bowel disease treatment market, by Type, 2014 to 2026
4.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
4.5.1. Crohn's disease
4.5.1.1. Crohn's disease market, 2014 - 2026 (USD Million)
4.5.2. Ulcerative colitis
4.5.2.1. Ulcerative colitis market, 2014 - 2026 (USD Million)
Chapter 5. Inflammatory Bowel Disease Treatment Market: Route of Administration Estimates & Trend Analysis
5.1. Definitions & Scope
5.2. Route of administration market share analysis, 2018 & 2026
5.3. Route of Administration Dashboard
5.4. Global Inflammatory bowel disease treatment market, by route of administration, 2014 to 2026
5.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
5.5.1. Oral
5.5.1.1. Oral market, 2014 - 2026 (USD Million)
5.5.1.2. ASAs
5.5.1.2.1. ASAs market, 2014 - 2026 (USD Million)
5.5.1.3. Corticosteroids
5.5.1.3.1. Corticosteroids market, 2014 - 2026 (USD Million)
5.5.1.4. JAK inhibitors
5.5.1.4.1. JAK inhibitors market, 2014 - 2026 (USD Million)
5.5.1.5. Others
5.5.1.5.1. Others market, 2014 - 2026 (USD Million)
5.5.2. Injectables
5.5.2.1. Injectables market, 2014 - 2026 (USD Million)
5.5.2.2. TNF inhibitors
5.5.2.2.1. TNF inhibitors market, 2014 - 2026 (USD Million)
5.5.2.3. IL inhibitors
5.5.2.3.1. IL inhibitors market, 2014 - 2026 (USD Million)
5.5.2.4. Anti-integrin
5.5.2.4.1. Anti-integrin market, 2014 - 2026 (USD Million)
5.5.2.5. Others
5.5.2.5.1. Others market, 2014 - 2026 (USD Million)
Chapter 6. Inflammatory Bowel Disease Treatment Market: Distribution Channel Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. Distribution channel market share analysis, 2018 & 2026
6.3. Distribution Channel Dashboard
6.4. Global Inflammatory bowel disease treatment market, by Distribution Channel, 2014 to 2026
6.5. Market Size & Forecasts and Trend Analyses, 2014 to 2026 for the following,
6.5.1. Hospital Pharmacy
6.5.1.1. Hospital Pharmacy market, 2014 - 2026 (USD Million)
6.5.2. Retail Pharmacy
6.5.2.1. Retail Pharmacy solutions market, 2014 - 2026 (USD Million)
6.5.3. Online Pharmacy
6.5.3.1. Online Pharmacy market, 2014 - 2026 (USD Million)
Chapter 7. Inflammatory Bowel Disease Treatment Market: Regional Estimates & Trend analysis, by type, route of administration and distribution channel
7.1. Regional Market Snapshot
7.2. Regional Market Share and Leading Players, 2018
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
7.3.1. North America
7.3.2. Europe
7.3.3. Asia Pacific
7.3.4. Latin America
7.3.5. Middle East & Africa
7.4. Market Size, & Forecasts, and Trend Analysis, 2018 to 2026:
7.4.1. North America
7.4.1.1. North America inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.1.2. U.S.
7.4.1.2.1. U.S. inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.1.3. Canada
7.4.1.3.1. Canada inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.2. Europe
7.4.2.1. Europe inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.2.2. U.K.
7.4.2.2.1. U.K. inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.2.3. Germany
7.4.2.3.1. Germany inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.2.4. Spain
7.4.2.4.1. Spain inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.2.5. France
7.4.2.5.1. France inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.2.6. Italy
7.4.2.6.1. Italy inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.3. Asia Pacific
7.4.3.1. Asia Pacific inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.3.2. China
7.4.3.2.1. China inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.3.3. Japan
7.4.3.3.1. Japan inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.3.4. India
7.4.3.4.1. India inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.3.5. South Korea
7.4.3.5.1. South Korea inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.3.6. Singapore
7.4.3.6.1. Singapore inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.3.7. Australia
7.4.3.7.1. Australia inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.4. Latin America
7.4.4.1. Latin America inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.4.2. Brazil
7.4.4.2.1. Brazil inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.4.3. Mexico
7.4.4.3.1. Mexico inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.4.4. Argentina
7.4.4.4.1. Argentina inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.5. Middle East Africa
7.4.5.1. MEA inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.5.2. South Africa
7.4.5.2.1. South Africa inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.5.3. Saudi Arabia
7.4.5.3.1. Saudi Arabia inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
7.4.5.4. UAE
7.4.5.4.1. UAE inflammatory bowel disease treatment market, 2014 - 2026 (USD Million)
Chapter 8. Company Profiles
8.1. Recent developments & impact analysis, by key market participants
8.2. Company/Competition Categorization (Key innovators, Market leaders, Emerging players)
8.3. Public Companies
8.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
8.3.2. Company Market Share/Ranking, by region
8.3.3. Competitive Dashboard Analysis
8.3.4. Market Differentiators
8.4. Private Companies
8.4.1. List of key emerging companies' /technology disruptors/innovators
8.4.2. Regional network map
8.4.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
8.5. Strategic Framework
8.5.1. Johnson & Johnson Services Inc.
8.5.1.1. Company Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Pfizer Inc.
8.5.2.1. Company Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Takeda Pharmaceutical Company Limited
8.5.3.1. Company Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. AbbVie Inc.
8.5.4.1. Company Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Celltrion Healthcare Co., Ltd.
8.5.5.1. Company Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. CELGENE CORPORATION
8.5.6.1. Company Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. COSMO PHARMACEUTICALS
8.5.7.1. Company Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Innovate Biopharmaceuticals
8.5.8.1. Company Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. UCB S.A
8.5.9.1. Company Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Gilead Sciences
8.5.10.1. Company Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
List of Tables TABLE 1 List of Abbreviation TABLE 2 North America Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 3 North America Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 4 North America Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 5 North America Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 6 North America Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 7 U.S. Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 8 U.S. Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 9 U.S. Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 10 U.S. Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 11 U.S. Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 12 Canada Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 13 Canada Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 14 Canada Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 15 Canada Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 16 Canada Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 17 Europe Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 18 Europe Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 19 Europe Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 20 Europe Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 21 Europe Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 22 U.K. Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 23 U.K. Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 24 U.K. Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 25 U.K. Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 26 U.K. Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 27 Germany Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 28 Germany Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 29 Germany Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 30 Germany Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 31 Germany Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 32 Italy Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 33 Italy Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 34 Italy Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 35 Italy Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 36 Italy Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 37 France Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 38 France Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 39 France Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 40 France Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 41 France Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 42 Spain Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 43 Spain Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 44 Spain Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 45 Spain Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 46 Spain Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 47 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 48 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 49 Asia Pacific Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 50 Asia Pacific Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 51 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 52 Japan Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 53 Japan Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 54 Japan Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 55 Japan Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 56 Japan Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 57 China Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 58 China Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 59 China Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 60 China Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 61 China Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 62 India Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 63 India Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 64 India Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 65 India Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 66 India Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 67 South Korea Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 68 South Korea Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 69 South Korea Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 70 South Korea Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 71 South Korea Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 72 Australia Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 73 Australia Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 75 Australia Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 76 Australia Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 77 Australia Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 78 Singapore Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 79 Singapore Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 80 Singapore Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 81 Singapore Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 82 Singapore Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 83 Latin America Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 84 Latin America Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 85 Latin America Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 86 Latin America Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 87 Latin America Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 88 Brazil Inflammatory Bowel Disease Market, By Type, 2014 - 2026 (USD Million) TABLE 89 Brazil Inflammatory Bowel Disease Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 90 Brazil Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 91 Brazil Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 92 Brazil Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 93 Mexico Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 94 Mexico Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 95 Mexico Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 96 Mexico Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 97 Mexico Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 98 Argentina Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 99 Argentina Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 100 Argentina Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 101 Argentina Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 102 Argentina Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 103 MEA Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 104 MEA Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 105 MEA Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 106 MEA Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 107 MEA Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 108 South Africa Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 109 South Africa Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 110 South Africa Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 111 South Africa Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 112 South Africa Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 113 UAE Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 114 UAE Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 115 UAE Oral Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 116 UAE Injectables Market, By Drug Class, 2014 - 2026 (USD Million) TABLE 117 UAE Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million) TABLE 118 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Type, 2014 - 2026 (USD Million) TABLE 119 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2014 - 2026 (USD Million) TABLE 120 Saudi Arabia Oral Market, By Drug Class, 2014 - 2026 (USD Million) Table 121 Saudi Arabia Injectables Market, By Drug Class, 2014 - 2026 (USD Million) Table 122 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2014 - 2026 (USD Million)
List of Figures FIG. 1 Market research process FIG. 2 Information procurement FIG. 3 Market summary FIG. 4 Market segmentation & scope FIG. 5 Market size and growth prospects FIG. 6 Global inflammatory bowel disease treatment market- Key market driver analysis FIG. 7 Global inflammatory bowel disease treatment market - Key market restraint analysis FIG. 8 Penetration & growth prospect mapping FIG. 9 Factors estimated to impact on market growth FIG. 10 Global inflammatory bowel disease treatment market - Porter's analysis FIG. 11 Global inflammatory bowel disease treatment market - PESTEL analysis FIG. 12 Global inflammatory bowel disease treatment market type outlook key takeaways FIG. 13 Global inflammatory bowel disease treatment market: Type movement analysis FIG. 14 Crohn's disease market estimates, 2014 - 2026 (USD Million) FIG 15 Ulcerative colitis agents market estimates, 2014 - 2026 (USD Million) FIG. 16 Global inflammatory bowel disease treatment market route of administration outlook key takeaways FIG. 17 Global inflammatory bowel disease treatment market: Route of Administration movement analysis FIG. 18 Oral market estimates, 2014 - 2026 (USD Million) FIG. 19 ASAs market estimates, 2014 - 2026 (USD Million) FIG. 20 Corticosteroids market estimates, 2014 - 2026 (USD Million) FIG. 21 JAK inhibitors market estimates, 2014 - 2026 (USD Million) FIG. 22 Others market estimates, 2014 - 2026 (USD Million) FIG. 23 Injectables market estimates, 2014 - 2026 (USD Million) FIG. 24 TNF inhibitors market estimates, 2014 - 2026 (USD Million) FIG. 25 IL inhibitors market estimates, 2014 - 2026 (USD Million) FIG. 26 Anti-integrins market estimates, 2014 - 2026 (USD Million) FIG. 27 Others market estimates, 2014 - 2026 (USD Million) FIG. 28 Global inflammatory bowel disease treatment market distribution channel outlook key takeaways FIG. 29 Global inflammatory bowel disease treatment market: Distribution channel movement analysis FIG. 30 Hospital pharmacy market estimates, 2014 - 2026 (USD Million) FIG. 31 Retail pharmacy solutions market estimates, 2014 - 2026 (USD Million) FIG. 32 Online pharmacy market estimates, 2014 - 2026 (USD Million) FIG. 33 Regional market place: Key takeaways FIG. 34 Global inflammatory bowel disease treatment market: Regional movement analysis FIG. 35 North America inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 36 U.S. inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 37 Canada inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 38 Europe inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 39 U.K. inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 40 Germany inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 41 France inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 42 Spain inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 43 Italy inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 44 Asia Pacific inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 45 Japan inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 46 China inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 47 India inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 48 South Korea inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 49 Singapore inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 50 Australia inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 51 Latin America inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG 52 Brazil inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 53 Mexico inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 54 Argentina inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 55 MEA inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 56 South Africa inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 57 UAE market, 2014 - 2026 (USD Million) FIG. 58 Saudi Arabia inflammatory bowel disease treatment market, 2014 - 2026 (USD Million) FIG. 59 Strategy framework
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
